These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


300 related items for PubMed ID: 23458386

  • 1. Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo.
    Okamatsu A, Motoyama K, Onodera R, Higashi T, Koshigoe T, Shimada Y, Hattori K, Takeuchi T, Arima H.
    Bioconjug Chem; 2013 Apr 17; 24(4):724-33. PubMed ID: 23458386
    [Abstract] [Full Text] [Related]

  • 2. Design and evaluation of folate-appended α-, β-, and γ-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo.
    Okamatsu A, Motoyama K, Onodera R, Higashi T, Koshigoe T, Shimada Y, Hattori K, Takeuchi T, Arima H.
    Biomacromolecules; 2013 Dec 09; 14(12):4420-8. PubMed ID: 24175976
    [Abstract] [Full Text] [Related]

  • 3. Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter.
    Saito S, Koya Y, Kajiyama H, Yamashita M, Kikkawa F, Nawa A.
    Cancer Sci; 2020 May 09; 111(5):1794-1804. PubMed ID: 32154964
    [Abstract] [Full Text] [Related]

  • 4. Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin.
    Kameyama K, Motoyama K, Tanaka N, Yamashita Y, Higashi T, Arima H.
    Int J Nanomedicine; 2017 May 09; 12():3433-3446. PubMed ID: 28496320
    [Abstract] [Full Text] [Related]

  • 5. Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier.
    Arima H, Yoshimatsu A, Ikeda H, Ohyama A, Motoyama K, Higashi T, Tsuchiya A, Niidome T, Katayama Y, Hattori K, Takeuchi T.
    Mol Pharm; 2012 Sep 04; 9(9):2591-604. PubMed ID: 22873579
    [Abstract] [Full Text] [Related]

  • 6. Active Drug Targeting of a Folate-Based Cyclodextrin-Doxorubicin Conjugate and the Cytotoxic Effect on Drug-Resistant Mammary Tumor Cells In Vitro.
    Mizusako H, Tagami T, Hattori K, Ozeki T.
    J Pharm Sci; 2015 Sep 04; 104(9):2934-40. PubMed ID: 25940848
    [Abstract] [Full Text] [Related]

  • 7. Potential use of folate-polyethylene glycol (PEG)-appended dendrimer (G3) conjugate with α-cyclodextrin as DNA carriers to tumor cells.
    Arima H, Arizono M, Higashi T, Yoshimatsu A, Ikeda H, Motoyama K, Hattori K, Takeuchi T, Hirayama F, Uekama K.
    Cancer Gene Ther; 2012 May 04; 19(5):358-66. PubMed ID: 22402627
    [Abstract] [Full Text] [Related]

  • 8. Dual targeting system by supramolecular complex of folate-conjugated methyl-β-cyclodextrin with adamantane-grafted hyaluronic acid for the treatment of colorectal cancer.
    Elamin KM, Motoyama K, Higashi T, Yamashita Y, Tokuda A, Arima H.
    Int J Biol Macromol; 2018 Jul 01; 113():386-394. PubMed ID: 29486262
    [Abstract] [Full Text] [Related]

  • 9. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
    Su C, Li H, Shi Y, Wang G, Liu L, Zhao L, Su R.
    Int J Pharm; 2014 Oct 20; 474(1-2):202-11. PubMed ID: 25149123
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: in vitro and in vivo evaluation.
    Xiong Q, Zhang M, Zhang Z, Shen W, Liu L, Zhang Q.
    Int J Pharm; 2014 Oct 20; 474(1-2):232-40. PubMed ID: 25149124
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C, Zhao L, Dong Y, Zhang X, Lin J, Chen Z.
    Eur J Pharm Biopharm; 2010 Sep 20; 76(1):10-6. PubMed ID: 20472060
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.